{
  "source_pdf": "data/clinical_files/Liu et al. (2024).pdf",
  "blocks": [
    {
      "id": "c3da45a2",
      "page_index": 0,
      "role": "Text",
      "bbox": [
        1193.9781494140625,
        1925.43505859375,
        3106.868896484375,
        3493.304443359375
      ],
      "text": "pes o o g epeat acc a mbinant or cell culture based ed inﬂuenza vaccines Feng Liu 1, F. Lia in i Gross 1, Sneha Joshi 1, Manju sha Gag lani 2,3,4, Allison L. Naleway5, Kemp a pura Mur thy 4, Holly C. Groom 5, Meredith G. Wesley 1 6, Laura J. Edwards 6, Lauren Grant 1, Sara S. Kim1, Surya prakash Sambhara1, Shiva prakash Gang appa 1, Terrence Tum pey 1, Mark G. Thompson 1, Alicia M. Fry1, Brendan Flannery 1, Fatimah S. Dawood1 & Min Z. Levine 1 Repeat vaccination with egg based inﬂuenza vaccines could preferentially boost antibodies targeting the egg adapted epi to pes and reduce immuno- geni city to circulating viruses. In this randomized trial (Clinical trials gov: NCT03722589), sera pre- and post vaccination with quad rival ent in activated egg based (IIV4), cell culture based (ccIIV4), and recombinant (RIV4) inﬂuenza vaccines were collected from healthcare personnel (18-64 years) in 2018 19 (N = 723) and 2019 20 (N = 684) inﬂuenza seasons. We performed an",
      "metadata": {
        "score": 0.9801412224769592,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0025649070739746094,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "6bba299e",
      "page_index": 0,
      "role": "Title",
      "bbox": [
        150.431396484375,
        600.9791870117188,
        3074.566162109375,
        1273.9129638671875
      ],
      "text": "year 1, but there was no sign i cant difference in HA stalk antibody fold rise among vaccine groups in either year 1 or year 2. Multiple seasons of non egg based vaccination may be needed to redirect antibody responses from immune memory to egg adapted epi to pes and re-focus the immune response towards epi to pes on the circulating viruses to improve vaccine effective nes Inﬂuenza viruses are a common cause of respiratory infections in humans, annual inﬂuenza vaccination has been recommended in the U it d St t (US) f d d C ti ll i ﬂ manufacturing process can lead to egg adapted mutations in th hemagglutinin (HA) protein in IIV, that could result in altered an i it d d d i ff ti (VE) i t th i l ti",
      "metadata": {
        "score": 0.9274311065673828,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0012247562408447266,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "27ced49e",
      "page_index": 0,
      "role": "Text",
      "bbox": [
        1696.6844482421875,
        3639.881591796875,
        3134.375244140625,
        3969.018798828125
      ],
      "text": "https://doi.org/10.1038/s41467-023-44551-x responses from egg-",
      "metadata": {
        "score": 0.9915224313735962,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.00021910667419433594,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "d04ead38",
      "page_index": 0,
      "role": "Text",
      "bbox": [
        204.8130645751953,
        3646.549072265625,
        1652.098388671875,
        3973.61669921875
      ],
      "text": "Article Redirecting antibody r",
      "metadata": {
        "score": 0.9896141886711121,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.00009393692016601562,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "d43d597f",
      "page_index": 0,
      "role": "Text",
      "bbox": [
        186.0461883544922,
        4069.9462890625,
        1830.0548095703125,
        4138.34521484375
      ],
      "text": "",
      "metadata": {
        "score": 0.9532380104064941,
        "detection_dpi": 400,
        "extraction_status": "empty"
      }
    },
    {
      "id": "97e3efc5",
      "page_index": 0,
      "role": "List",
      "bbox": [
        1194.2193603515625,
        1432.138671875,
        3148.730712890625,
        1823.8802490234375
      ],
      "text": "A (H3N2) immunogen i city. In year 1, RIV4 induced higher neutralizing and total HA head binding antibodies to cell- A (H3N2) virus than ccIIV4 and IIV4. In year 2, among the 7 repeat vaccination arms (IIV4-IIV4, IIV4-ccIIV4, IIV4-RIV4, RIV4- ccIIV4, RIV4-RIV4, ccIIV4-ccIIV4 and ccIIV4-RIV4), repeat vaccination with either RIV4 or ccIIV4 further improved antibody responses to circulating iruses ith decreased neutral i ing anti bod egg cell ratio RIV4 also had",
      "metadata": {
        "score": 0.49818384647369385,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0006239414215087891,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "de61779d",
      "page_index": 0,
      "role": "Table",
      "bbox": [
        210.19276428222656,
        1479.7440185546875,
        1161.05517578125,
        3565.42138671875
      ],
      "text": "[TABLE 4 - See table_p1_de61779d.png]",
      "image_path": "figures/table_p1_de61779d.png",
      "metadata": {
        "score": 0.32636532187461853,
        "detection_dpi": 400
      }
    },
    {
      "id": "ae95965e",
      "page_index": 0,
      "role": "Title",
      "bbox": [
        208.948974609375,
        509.4339599609375,
        402.98480224609375,
        598.6935424804688
      ],
      "text": "United St cine seed",
      "metadata": {
        "score": 0.2558126449584961,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.00006794929504394531,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "332637ad",
      "page_index": 1,
      "role": "Figure",
      "bbox": [
        297.57305908203125,
        2305.639404296875,
        3025.63427734375,
        3983.588623046875
      ],
      "text": "[FIGURE 3 - See figure_p2_332637ad.png]",
      "image_path": "figures/figure_p2_332637ad.png",
      "metadata": {
        "score": 0.9980144500732422,
        "detection_dpi": 400
      }
    },
    {
      "id": "12410438",
      "page_index": 1,
      "role": "Text",
      "bbox": [
        208.7605438232422,
        924.3555297851562,
        1650.419677734375,
        2199.82275390625
      ],
      "text": "during the preceding ﬁve seasons. Year 1 (2018-201 ccIIV4 n=283 18-44 years: n=135 45-64 years: n=148 Completed day 0 (n=283) 1 month (n=280) and 6 months (n=266) visit RIV n=198 18-44 years: n=99 45-64 years: n=99 Completed day 0 (n=197 1 month (n=196) and 6 months (n=177) visit Year 2: Year 1 participants IIV4 in Year 1 n=318 (*139) Re-randomized to ccIIV4, RIV4, or IIV4 318 (*139) Year 1: 2018-2019 Year 2: 2019-2020",
      "metadata": {
        "score": 0.9913740754127502,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0005340576171875,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "ed776aac",
      "page_index": 1,
      "role": "Text",
      "bbox": [
        1683.02490234375,
        1059.123046875,
        3126.04443359375,
        2252.9833984375
      ],
      "text": "sas/14/2017 (H3N2) like virus respectively while the B/Victoria and B/ Yamagata components remained the same (Table 1). Enrolled and Randomized n=723 Vaccine Allocation Flu zone IIV4 n=122 18-44 years: n=57 45-64 years: n=65 Completed day 0 (n=110) 1 month (n=110) and 6 months (n=101) visit Fluarix IIV4 n=120 18-44 years: n=55 45-64 years: n=65 Completed day 0 (n=120) 1 month (n=118) and 6 months (n=107) visit re-enrolled in Year 2 and new enroll ees randomized n=684 (139*) ccIIV4 in Year 1 n=214 RIV4 in Year 1 n=152",
      "metadata": {
        "score": 0.9806641340255737,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0007061958312988281,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "bc3de884",
      "page_index": 1,
      "role": "Text",
      "bbox": [
        204.54901123046875,
        242.55282592773438,
        1655.338623046875,
        888.626953125
      ],
      "text": "IIV4-ccIIV4 n=106 (*51) IIV4-RIV4 n=104 (*44) IIV4-IIV4 n=103 (*41) Excluded n=5 Did not meet per protocol criteria Fig. 1 | CONSORT diagrams for screening and Enrollment of participants in Year 1 (2018-2019 and Year 2 (2019-2020. Abbreviations: IIV4: In activated inﬂuenza vaccine (Flu zone or Fluarix® Quad rival ent; ccIIV4: Cell culture based IIV",
      "metadata": {
        "score": 0.9954648613929749,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0006508827209472656,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "7104fc5f",
      "page_index": 1,
      "role": "Text",
      "bbox": [
        1688.642822265625,
        243.80490112304688,
        3126.882568359375,
        876.6522827148438
      ],
      "text": "RIV4-RIV4 n=74 ccIIV4-RIV4 n=106 ccIIV4-ccIIV4 n=101 RIV4-ccIIV4 n=73 Excluded n=12 Did not meet per protocol criteria (Flu cel vax Quad rival ent; RIV4: recombinant hemagglutinin inﬂuenza vaccine (Flublok® Quad rival ent. *Numbers in parenthesis are new enroll ees for Year 2.",
      "metadata": {
        "score": 0.9883090257644653,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0005297660827636719,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "80465f33",
      "page_index": 1,
      "role": "Title",
      "bbox": [
        1692.080322265625,
        905.1456298828125,
        1918.791748046875,
        991.0996704101562
      ],
      "text": "",
      "metadata": {
        "score": 0.996778666973114,
        "detection_dpi": 400,
        "extraction_status": "empty"
      }
    },
    {
      "id": "ba740d83",
      "page_index": 2,
      "role": "Table",
      "bbox": [
        217.03028869628906,
        400.4718933105469,
        3204.41259765625,
        2433.71630859375
      ],
      "text": "[TABLE 2 - See table_p3_ba740d83.png]",
      "image_path": "figures/table_p3_ba740d83.png",
      "metadata": {
        "score": 0.9781708121299744,
        "detection_dpi": 400
      }
    },
    {
      "id": "46957b27",
      "page_index": 2,
      "role": "Text",
      "bbox": [
        207.96681213378906,
        3040.47998046875,
        1647.5260009765625,
        4084.103271484375
      ],
      "text": "| gg p the study Viruses Amino acids differences A (H1N1) pdm09 45 74 120 Year 1 A/Michigan/45/2015 cell a R S T A/Michigan/45/2015 egg R S T A/Michigan/45/2015 X-275 egg CVV (EPI 830246 b R S T A/Singapore/GP1908/2015 IVR-180 egg CVV (EPI 848715 c, d R S A Year 2 A/Idaho/07/2018 cell a, d R R T A/Brisbane/02/2018 egg b G R T A (H3N2) 91 121 128 Year 1 A/Singapore/INFIMH-16-0019/2016 cell a S K T A/Singapore/INFIMH-16-0019/2016 egg S K T A/Singapore/INFIMH-16-0019/2016 IVR-186 egg CVV (EPI 1082512 b S K T",
      "metadata": {
        "score": 0.9942084550857544,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0008862018585205078,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "90fd2f83",
      "page_index": 2,
      "role": "Text",
      "bbox": [
        1684.048095703125,
        3221.31201171875,
        3132.126220703125,
        4085.61669921875
      ],
      "text": "n of egg grown vaccine viruses and CVVs in year 1 and year 2 of on the HA head domain 164 183 209 223 225 282 295 298 S S K Q G P I I S S K R G P I I S S M R G P I I S S K Q A P I I T P K Q G P V I T P K R G A V V 138 142 144 158 159 160 171 190 193 194 225 246 311 A G S N (CHO) Y T K D F L D N H",
      "metadata": {
        "score": 0.9906999468803406,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0001361370086669922,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "9020031b",
      "page_index": 2,
      "role": "Text",
      "bbox": [
        239.07911682128906,
        2479.536376953125,
        2500.871337890625,
        2845.742431640625
      ],
      "text": "Year 2 A/Kansas/14/2017 cell a, d N N A S G K N (CHO-) S K N A/Kansas/14/2017 egg b N N A S G K N (CHO-) S K N B/Victoria lineage 129 197 199 Year 1 & 2 B/Colorado/06/2017 cell G N T B/Colorado/06/2017 egg G T (CHO-) T B/Maryland/15/2016 BX-69A egg CVV D N (CHO-) I",
      "metadata": {
        "score": 0.9546775221824646,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.00012111663818359375,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "dbed8dfa",
      "page_index": 2,
      "role": "Text",
      "bbox": [
        1663.4962158203125,
        2933.738037109375,
        3139.481201171875,
        3074.825927734375
      ],
      "text": "A G S N (CHO-) Y K K D F P G N H",
      "metadata": {
        "score": 0.9337063431739807,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0000247955322265625,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "74fc894d",
      "page_index": 2,
      "role": "Text",
      "bbox": [
        221.56568908691406,
        257.7184753417969,
        3100.875244140625,
        395.7984619140625
      ],
      "text": ", g y y motif at HA position 197; whereas egg based B/Yamagata vaccine had g y g (p ) p antibody responses to both egg- (GMT 122) and cell- (GMT 137",
      "metadata": {
        "score": 0.8624834418296814,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.00017380714416503906,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "896d15ed",
      "page_index": 3,
      "role": "Figure",
      "bbox": [
        268.964111328125,
        221.76206970214844,
        3023.11572265625,
        1972.015380859375
      ],
      "text": "[FIGURE 1 - See figure_p4_896d15ed.png]",
      "image_path": "figures/figure_p4_896d15ed.png",
      "metadata": {
        "score": 0.9924536347389221,
        "detection_dpi": 400
      }
    },
    {
      "id": "bf700b25",
      "page_index": 3,
      "role": "Text",
      "bbox": [
        1721.01416015625,
        2891.9697265625,
        3116.74072265625,
        4130.22607421875
      ],
      "text": "45-64 yrs egg virus 45-64 yrs cell virus Day 0 1 m 6 m 5 10 20 40 80 160 320 640 1280-2560 5120 0.045 0 0046 <0 0001 0.03 0 0074 Day 0 1 m 6 m 5 10 20 40 80 160 320 640 1280-2560 5120 Flu zone IIV4 Fluarix IIV4 ccIIV4 RIV4 <0 0001 <0 0001 <0 0001 <0 0001 <0 0001 0.004 Day 0 1 m 6 m 5 10 20 40 80 160 320 640 1280-2560 5120 0 0041 0 0072 Day 0 1 m 6 m 5 10 20 40 80 160 320 640 1280-2560 5120 0.032 0 0009 0 0165 10 20 40 80 160 320 640 1280-2560 5120 10 20 40 80 160 320 640 1280-2560 5120",
      "metadata": {
        "score": 0.9769856929779053,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0006740093231201172,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "09c80957",
      "page_index": 3,
      "role": "Text",
      "bbox": [
        216.22601318359375,
        2557.59326171875,
        1653.267822265625,
        3395.34521484375
      ],
      "text": "B/VIC B/YAM Day 0 1 m 6 m 5 10 20 40 HI tite Day 0 1 m 6 m 5 10 20 40 Day 0 1 m 6 m 5 10 20 40 80 160 320 640 1280-2560 5120 HI titers (Log2 scale) Day 0 1 m 6 m 5 10 20 40 80 160 320 640 1280-2560 5120 40 80 160 320 640 1280-2560 5120 ters (Log2 scale) 40 80 160 320 640 1280-2560 5120 0.035 0.019 0.0",
      "metadata": {
        "score": 0.993614912033081,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.00022792816162109375,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "b931e8ed",
      "page_index": 3,
      "role": "Text",
      "bbox": [
        212.2407989501953,
        3430.5732421875,
        1623.4273681640625,
        4148.66650390625
      ],
      "text": "A (H3N2) A (H1N1) pdm09 18-44 yrs egg virus 18-44 yrs cell virus Day 0 1 m 6 m 5 10 20 40 80 160 320 640 1280-2560 5120 MN titers (Log2 scale) 0.003 0.014 <0 0001 0 0008 0.044 <0 0001 Day 0 1 m 6 m 5 10 20 40 80 160 320 640 1280-2560 5120 0 0024 <0 0001 <0 0001 0 0085 < 0.0 160 320 640 1280-2560 5120 (Log2 scale) 0.02 160 320 640 1280-2560 5120 0.003",
      "metadata": {
        "score": 0.9970220923423767,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0004379749298095703,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "af7e3b71",
      "page_index": 3,
      "role": "Text",
      "bbox": [
        1698.427001953125,
        1988.657958984375,
        3149.030029296875,
        2464.791748046875
      ],
      "text": "Day 0 1 m 6 m Day 0 1 m 6 m ccIIV4 45−64 years: Day 0 (n = 148), 1 m (n = 147), 6 m (n = 142); RIV4 18−44 years: Day 0 (n = 99), 1 m (n = 98), 6 m (n = 85); RIV4 45−64 years: Day 0 (n = 98), 1 m (n = 98), 6 m (n = 92); Micro neutralization titers (MN) were measured for A (H3N2) virus, while hemagglutination inhibition (HI) titers were measured for A (H1N1) pdm09, B/Victoria (B/VIC), and B/Yamagata (B/YAM) viruses. One way ANOVA corrected for multiple comparisons (Tukey’s test) was used to compare the GMTs of each time point among the 4 vaccine groups. Statistically sign i cant differences b i di d b l h h i l b",
      "metadata": {
        "score": 0.9832895994186401,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0009179115295410156,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "2c8a6aa8",
      "page_index": 3,
      "role": "Text",
      "bbox": [
        191.19422912597656,
        2000.1619873046875,
        1661.53857421875,
        2523.52294921875
      ],
      "text": "Day 0 1 m 6 m 5 10 H Day 0 1 m 6 m 5 10 20 Fig. 2 | MN or HI Antibody responses to egg- and cell propagated vaccine viruses at pre vaccination (Day 0), 1 month, and 6 months post vaccination in Year 1. Antibody titers from each of the four vaccine groups were presented as geometric mean titers (GMTs) with 95% conﬁdence interval (CI) respectively for 18−44 years and 45−64 years age groups. Gray dots represented individual titers. Flu zone IIV4 18−44 years: Day 0 (n = 52), 1 m (n = 52), 6 m (n = 47); Flu zone IIV4 45- 64 years: Day 0 (n = 58), 1 m (n = 58), 6 m (n = 54); Fluarix IIV4 18−44 years: Day 0",
      "metadata": {
        "score": 0.957872748374939,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0008370876312255859,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "9c9aa4f0",
      "page_index": 3,
      "role": "Text",
      "bbox": [
        1696.4083251953125,
        2575.158935546875,
        3133.809326171875,
        2835.22119140625
      ],
      "text": "80 160 320 640 1280-2560 5120 0.018 80 160 320 640 1280-2560 5120",
      "metadata": {
        "score": 0.9855533242225647,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0000629425048828125,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "a8f63755",
      "page_index": 4,
      "role": "Figure",
      "bbox": [
        250.22955322265625,
        236.13424682617188,
        3035.725830078125,
        1235.07177734375
      ],
      "text": "[FIGURE 1 - See figure_p5_a8f63755.png]",
      "image_path": "figures/figure_p5_a8f63755.png",
      "metadata": {
        "score": 0.9958594441413879,
        "detection_dpi": 400
      }
    },
    {
      "id": "95d6b527",
      "page_index": 4,
      "role": "Text",
      "bbox": [
        1690.57861328125,
        2230.037841796875,
        3132.59423828125,
        3765.111328125
      ],
      "text": "A (H1N1) pdm09 and B/Yamagata, the post vaccination HI antibody GMT egg cell titer ratios were all <2 and similar (p > 0.05) among the vaccine groups (Fig. 5A, B). For B/Victoria, the post vaccination HI GMT egg cell titer ratios were slightly elevated (range: 2−3) with the ratio in Flu zone IIV4 recipients signiﬁcantly higher (p < 0.05) than those in 0 1 0 1 2 3 4 45-64 years 0.002 0.003 0.036 0.002 0 0002 <0 0001 Flu zone IIV4 Fluarix IIV4 ccIIV4 RIV4 Geometric mean fold reduction of antibody ti post vaccination (95%CI) H3N2 egg H3N2 cell H1N1 egg H1N1 cell B/VIC egg B/VIC cell B/YAM cell B/YAM egg B/YAM egg H3N2 egg H3N2 cell H1N1 egg H1N1 cell B/VIC egg B/VIC cell B/YAM cell D 18−44 years (Flu zone IIV4 (n = 47), Fluarix IIV4 (n = 48), ccIIV4 (n = 124), RIV4 (n = 85)) and 45−64 years (Flu zone IIV4 (n = 54), Fluarix IIV4 (n = 59), ccIIV4 (n = 142), RIV4 (n = 92)) respectively (C, D). MN titers were measured for A (H3N2) virus, while HI titers were measured for A (H1N1) pdm09, B/VIC, and B/YAM viruses. One way ANOVA corrected for multiple comparisons (Tukey’s test) was used to compare the GM fold rise or fold reduction of each time point among the 4 vaccine groups. Statistically sign i cant differences between groups are indicated by p values on the horizontal bars.",
      "metadata": {
        "score": 0.9914820194244385,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0016410350799560547,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "0e817002",
      "page_index": 4,
      "role": "Text",
      "bbox": [
        211.5966033935547,
        2919.754150390625,
        1645.909912109375,
        3993.01171875
      ],
      "text": "0 1 2 3 4 5 6 18 44 years 0 0058 0 0088 0 0001 <0 0001 <0 0001 <0 0001 <0 0001 0 0006 0.021 0.047 0.034 0.004 0.005 0 0035 0.017 0 0003 0.024 0.01 0 1 2 3 4 5 6 45-64 years Flu zone IIV4 Fluarix IIV4 ccIIV4 RIV4 Fluarix IIV4 ccIIV4 RIV4 0 0021 0 0006 <0 0001 <0 0001 <0 0001 <0 0001 0.015 0 0023 0 0019 0.002 0.039 0.043 0 0004 0.03 Geometric mean fold rise of antibody titers 1 month post vaccination (95%CI) H3N2 egg H3N2 cell H1N1 egg H1N1 cell B/VIC egg B/VIC cell B/YAM cell B/YAM egg H3N2 egg H3N2 cell H1N1 egg H1N1 cell B/VIC egg B/VIC cell B/YAM cell B/YAM egg A B Fig. 3 | Fold rise of MN or HI antibody titers at 1 month post vaccination and waning of antibody titers at 6 months post vaccination in Year 1. Geometric mean (GM) fold rise of antibody titers (1 m/Day 0) from each of the four vaccine l l d f d ll d i i d f 18 44",
      "metadata": {
        "score": 0.9861876964569092,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0012149810791015625,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "ac784943",
      "page_index": 4,
      "role": "Text",
      "bbox": [
        213.71180725097656,
        1854.36572265625,
        1634.9405517578125,
        2577.29150390625
      ],
      "text": "Pre existing A (H3N2) and A (H1N1) pdm09 HA stalk antibodies were detected in participants at varies levels. Comparing HA stalk antibody titers at 1 month post vaccination versus day 0, vaccination signiﬁcantly boosted A (H1N1) pdm09 HA stalk antibodies in all 4 vac- cine groups (p < 0.01), and signiﬁcantly boosted A (H3N2) HA stalk antibodies in 3 of the 4 vaccine groups (p < 0.001, Flu zone IIV4, ccIIV4, and RIV4) (Fig. 4C). The RIV4 group had the highest A (H1N1) pdm09 HA stalk and A (H3N2) HA stalk antibodies at 1 month post vaccination, however the fold rises of HA stalk antibodies were low (<1.8) and similar among all 4 vaccine groups (Fig. 4D). At 6 months post-vacci- nation, waning of HA stalk antibodies were more notable in ccIIV4 and RIV4 d IIV4 (Fi S2)",
      "metadata": {
        "score": 0.9941832423210144,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0010890960693359375,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "7a9ad4c3",
      "page_index": 4,
      "role": "Text",
      "bbox": [
        1699.4188232421875,
        1281.63330078125,
        3129.920654296875,
        1752.1181640625
      ],
      "text": "participants had GMT egg cell ratio ≥4 to A (H3N2) and B/Victoria viruses, suggesting a high prevalence of pre existing neutralizing antibodies targeting HA egg adapted epi to pes in this highly vaccinated HCP population. After vaccination, in both age groups, the two egg- based vaccines generally reinforced the neutralizing antibody responses to egg adapted epi to pes as evidenced by an increased trend in the proportion of participants with GMT egg cell titer ratio ≥4. In contrast, among RIV4 and ccIIV4 recipients, the proportion of parti-",
      "metadata": {
        "score": 0.9787008166313171,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0009961128234863281,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "7754cba1",
      "page_index": 4,
      "role": "Text",
      "bbox": [
        1693.3402099609375,
        3777.919189453125,
        3119.499267578125,
        4141.76513671875
      ],
      "text": "2 3 4 18-44 years Flu zone IIV4 Fluarix IIV4 ccIIV4 RIV4 0.049 0.015 0.03 Waning 6 month fold reduction (1m/6m) ers 6 month C",
      "metadata": {
        "score": 0.9922869205474854,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.000240325927734375,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "0b85105e",
      "page_index": 4,
      "role": "Text",
      "bbox": [
        1680.72265625,
        1858.815185546875,
        3130.00927734375,
        2213.176025390625
      ],
      "text": "RIV4 recipients from the 45−64 years group (Fig. 5B). Next, to assess whether vaccination with non egg based vaccines can overcome the impact of egg adaptation and reduce the GMT egg/ cell ratio in the vaccine responses, we calculated the “proportion of the participants with egg cell ratio ≥4” in MN/HI titers at pre- and 1 month post vaccination (Fig. 5C, D). At pre vaccination, there was no sig- ﬁ d ff h f h / ll",
      "metadata": {
        "score": 0.9864529967308044,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0007760524749755859,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "3ad42e63",
      "page_index": 4,
      "role": "Text",
      "bbox": [
        215.98448181152344,
        1280.60693359375,
        1643.3271484375,
        1576.2210693359375
      ],
      "text": "Antibody responses to egg adapted epi to pes measured by antibody GMT egg cell titer ratio in year 1 To assess the levels of antibody responses targeting the egg adapted epi to pes, we used the antibody “GMT egg cell titer ratio” as a proxy to quantify the extent of difference in antibody responses to egg- versus",
      "metadata": {
        "score": 0.9900280833244324,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0005700588226318359,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "97aefe6e",
      "page_index": 4,
      "role": "Text",
      "bbox": [
        217.6690673828125,
        2583.86572265625,
        1655.9381103515625,
        2770.80029296875
      ],
      "text": "(n = 98)) age groups respectively (A, B). Antibody waning was expressed as the GM fold reduction of titers from 1 month to 6 months (1 m/6 m) post vaccination for",
      "metadata": {
        "score": 0.969057023525238,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0003390312194824219,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "11dd2a9a",
      "page_index": 4,
      "role": "Text",
      "bbox": [
        222.79408264160156,
        4008.08251953125,
        1676.7066650390625,
        4142.21435546875
      ],
      "text": "18 44 Flu zone IIV4 1 month fold rise (1m/Day 0)",
      "metadata": {
        "score": 0.9160634279251099,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.00009775161743164062,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "402687fb",
      "page_index": 4,
      "role": "Text",
      "bbox": [
        229.695556640625,
        1712.7447509765625,
        1627.9127197265625,
        1754.7298583984375
      ],
      "text": "year 1 a total of 26 breakthrough infection cases were identiﬁed with",
      "metadata": {
        "score": 0.7852168083190918,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": false,
          "processing_time": 0.00014090538024902344
        }
      }
    },
    {
      "id": "4bae8cb8",
      "page_index": 5,
      "role": "Figure",
      "bbox": [
        174.09205627441406,
        205.5261993408203,
        3094.45361328125,
        1930.0235595703125
      ],
      "text": "[FIGURE 1 - See figure_p6_4bae8cb8.png]",
      "image_path": "figures/figure_p6_4bae8cb8.png",
      "metadata": {
        "score": 0.9598800539970398,
        "detection_dpi": 400
      }
    },
    {
      "id": "0a953a42",
      "page_index": 5,
      "role": "Text",
      "bbox": [
        1693.366943359375,
        2742.764892578125,
        3118.4169921875,
        3689.760986328125
      ],
      "text": "Day 0 1 m 6 m 200 400 800 1600-3200 6400 Flu zone IIV4 Fluarix IIV4 ccIIV4 RIV4 0.02 0.043 0 0046 0.007 0.038 <0.000 1 0.044 * * * Day 0 1 m 6 m 200 400 800 1600-3200 6400-12800 25600 0 0036 <0 0001 0.03 0 0003 0 0017 <0 0001 0.016 <0 0001 0 0063 0.024 * * * * 4 Fl IIV4 C ELISA titers (Log2 scale) ELISA titers (Log2 scale) rise of (95% CI) H3 stalk H1 stalk D 6 m 0.049 0.015 6 m 0 0016 0 0039 <0 0001 0 0003 HA stalk ELISA titer fold rise (1m/day0)",
      "metadata": {
        "score": 0.9851794838905334,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0007407665252685547,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "081d90d3",
      "page_index": 5,
      "role": "Text",
      "bbox": [
        214.2630615234375,
        3423.016357421875,
        1637.095458984375,
        4142.52197265625
      ],
      "text": "A (H3N2) A (H1N1) pdm09 Egg virus HA Cell viru ELISA titers (Log2 scale) rs (Log2 scale) A Day 0 1 m 400 800 1600-3200 6400-12800 25600-51200 0.006 <0 0001 <0.000 3200-6400 12800-25600 51200 0.047 0 0001 0 0065 <0 0001 0.014 <0 0001 0 0082 <0 0001 0 0028 0 0055 0 0004 0.03 3200-6400 12800-25600 51200 0 0063 0 0011 0 0066 <0.000 0.011 <0.0 0 Day 0 1 m 6 m 400 800 1600-3200 6400-12800 25600-51200 0.047 0 0037 0.032 0.032 0.002 0.013 0.014",
      "metadata": {
        "score": 0.9952681660652161,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0006198883056640625,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "403049a3",
      "page_index": 5,
      "role": "Text",
      "bbox": [
        1686.2047119140625,
        1954.462158203125,
        3148.9521484375,
        2585.801025390625
      ],
      "text": "0 1 Geo met ELISA titer H3 stalk H1 stalk 6 m corrected for multiple comparisons (Tukey’s test) was used to compare the GMTs of each time point among the 4 vaccine groups (A, C). One way ANOVA non para metric Kruskal-Wallis test was used to compare the fold changes among the 4 vaccine groups (B, D). Statistically sign i cant differences between groups are indicated by p values on the horizontal bars.*: In (C), paired t test (two tailed was used for comparing the pre- and 1 m post vaccination stalk antibody titers within the same vaccine group: signiﬁcantly higher HA stalk antibody titers were detected in 1 m post vaccination than pre vaccination for H3 stalk binding antibody in Flu- zone IIV4 (p = 0 0009) ccIIV4 (p = 0 0004) RIV4 (p < 0 0001); and for H1 stalk",
      "metadata": {
        "score": 0.977586567401886,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.001210927963256836,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "8f40dd3e",
      "page_index": 5,
      "role": "Text",
      "bbox": [
        1689.3773193359375,
        3716.403076171875,
        3129.230712890625,
        4139.12890625
      ],
      "text": "HA eometric mean ratio of ELISA titer egg cell HA (95% CI) B H3 HA H1 HA B/VIC HA B/YAM HA 6 Flu zone IIV4 Fluarix IIV4 ccIIV4 RIV4 0.02 <0 0001 0 0002 0 1 2 3 4 Flu zone IIV4 Fluarix IIV4 ccIIV4 RIV4 0.009 <0 0001 <0 0001 0.002 0.041 0.03 0.006 0.016 Egg/Cell HA ELISA titer ratio (1m)",
      "metadata": {
        "score": 0.9938259124755859,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.00040030479431152344,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "680c82c4",
      "page_index": 5,
      "role": "Text",
      "bbox": [
        219.43099975585938,
        2116.634033203125,
        1644.885498046875,
        2432.62744140625
      ],
      "text": "Fig. 4 | Total HA binding antibody and HA stalk antibody responses measured by ELISA at pre vaccination (Day 0), 1 month, and 6 months post vaccination in Year 1. Antibody titers from each of the four vaccine groups were presented as geometric mean titers (GMTs) with 95% conﬁdence interval (CI) for combined 18−44 years and 45−64 years age groups. Gray dots represented individual titers. Flu zone IIV4: Day0 (n = 24) 1 m (n = 24) 6 m (n = 21); Fluarix IIV4: Day 0 (n = 24) 1 m",
      "metadata": {
        "score": 0.9733633399009705,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0008111000061035156,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "0f9df376",
      "page_index": 5,
      "role": "Text",
      "bbox": [
        221.27066040039062,
        3181.376220703125,
        1644.5335693359375,
        3389.4580078125
      ],
      "text": "ELISA ti Day 0 1 m 6 m 400 800 1600 Day 0 1 m 400 800 0.019 <0 0001 <0 0001 0 0088 0 0004 0 0007 0 036 0 015 51200 0 0011 <0 0001 0 0011 0.005 0.02 <0",
      "metadata": {
        "score": 0.9865587949752808,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0002720355987548828,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "c5b62358",
      "page_index": 5,
      "role": "Text",
      "bbox": [
        229.69573974609375,
        2458.49658203125,
        1630.880859375,
        2641.68798828125
      ],
      "text": "ELISA titers Day 0 1 m 6 m 400 800 1600-3200 Day 0 1 m 400 800 1600-3200",
      "metadata": {
        "score": 0.9572247266769409,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.00009799003601074219,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "de591114",
      "page_index": 5,
      "role": "Text",
      "bbox": [
        198.03298950195312,
        2757.94384765625,
        1646.92236328125,
        2950.394287109375
      ],
      "text": "ELIS le) Day 0 1 m 6 m 400 800 Day 0 1 m 400 800 51200 <0 0001 <0 0001 0 0011 0 0008 0 0002 <0 0001 0 0081 0.018 <0 0001-51200 <0 0001 <0 0001 0.005 0.004 <0 0001 <0 0001 <0.",
      "metadata": {
        "score": 0.9431552886962891,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0004031658172607422,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "4d3aadfe",
      "page_index": 5,
      "role": "Text",
      "bbox": [
        213.4172821044922,
        1962.3861083984375,
        1656.0291748046875,
        2080.868408203125
      ],
      "text": "(n = 24), 6 m (n = 23); ccIIV4: Day 0 (n = 56), 1 m (n = 54), 6 m (n = 51); RIV4: Day 0 (n = 40), 1 m (n = 40), 6 m (n = 38). A: HA (A (H1N1) pdm 09 or HA head (A (H3N2), B/ VIC B/YAM) binding antibodies B: Ratios of egg cell HA or HA head binding",
      "metadata": {
        "score": 0.8985437154769897,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.00026702880859375,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "0fa5a353",
      "page_index": 5,
      "role": "Title",
      "bbox": [
        194.13687133789062,
        2992.978271484375,
        1673.325439453125,
        3165.36962890625
      ],
      "text": "B/VIC ters (Log2 scale 3200-6400 12800-25600 51200-1600 3200-6400 12800-25600",
      "metadata": {
        "score": 0.68404221534729,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.00007200241088867188,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "3f1ebe73",
      "page_index": 6,
      "role": "Figure",
      "bbox": [
        259.0993347167969,
        230.04046630859375,
        3036.368896484375,
        1635.3433837890625
      ],
      "text": "[FIGURE 1 - See figure_p7_3f1ebe73.png]",
      "image_path": "figures/figure_p7_3f1ebe73.png",
      "metadata": {
        "score": 0.9949700236320496,
        "detection_dpi": 400
      }
    },
    {
      "id": "588256e6",
      "page_index": 6,
      "role": "Text",
      "bbox": [
        214.775146484375,
        2334.723876953125,
        1645.1329345703125,
        3401.305419921875
      ],
      "text": "A (H3N2) A (H1N1) pdm09 B/VIC B/YAM f o oit a r n a e m cirt e m o e G B 0 1 2 3 4 5 6 45-64 years Flu zone IIV4 Fluarix IIV4 ccIIV4 RIV4 <0 0001 <0 0001 0 0084 0.011 Fig. 5 | Difference in MN or HI antibody responses to egg adapted epi to pes stratiﬁed by age groups and vaccine type in Year 1. A, B: Geometric mean ratio of egg cell virus titers at 1 month post vaccination with 95% CI for each vaccine component among the 4 vaccine groups for 18-44 years (A Flu zone IIV4: n = 52, Fluarix IIV4: n = 55, ccIIV4: n = 133, RIV4: n = 98) and 45−64 years (B Flu zone IIV4: n = 58, Fluarix IIV4: n = 63, ccIIV4: n = 147, RIV4: n = 98) age groups. One way ANOVA non parametric Kruskal-Wallis test was used for comparison of geometric i f / ll i i h 4 i C D P i f",
      "metadata": {
        "score": 0.9934887886047363,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0010428428649902344,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "373de897",
      "page_index": 6,
      "role": "Text",
      "bbox": [
        1688.68603515625,
        2848.204345703125,
        3119.291015625,
        3577.984375
      ],
      "text": "0 Proportion of ≥4 -fold reduced titer to cell v 20 40 60 80 100 40% 21% Flu zone IIV4 Fluarix IIV4 ccIIV4 RIV4 A (H3N2) A (H1N1) pdm09 B/VIC B/YAM Pre Post Pre Post Pre Post Pre Post 45-64 years D p=0.005",
      "metadata": {
        "score": 0.9933773875236511,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.000209808349609375,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "e75aa04e",
      "page_index": 6,
      "role": "Text",
      "bbox": [
        216.72332763671875,
        3453.453369140625,
        1618.4404296875,
        4082.63134765625
      ],
      "text": "A (H3N2) A (H1N1) pdm09 B/VIC B/YAM ) I C % 5 9 ( r e tit s u riv lle c/ g g A 0 1 2 3 4 5 6 y Flu zone IIV4 Fluarix IIV4 ccIIV4 RIV4 0 0014 0 0021 0.03",
      "metadata": {
        "score": 0.9970946311950684,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.00017595291137695312,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "c88f85a2",
      "page_index": 6,
      "role": "Text",
      "bbox": [
        1700.7899169921875,
        1647.7314453125,
        3141.50634765625,
        2223.763427734375
      ],
      "text": "Comparing pre- and 1 month post vaccination, A (H3N2) HA stalk binding antibodies were signiﬁcantly boosted in ccIIV4-RIV4, RIV4-RIV4, IIV4-ccIIV4, and IIV4-RIV4 arms, while A (H1N1) pdm09 HA stalk binding antibodies were also signiﬁcantly boosted in ccIIV4-ccIIV4 and RIV4-ccIIV4 arms (Fig. 8C). However, fold rise in both A (H1N1) pdm09 HA stalk and A (H3N2) HA stalk antibodies were low (GM fold rise <1.78) with no sig- niﬁcant difference (p > 0.05) among all 7 repeat vaccination arms (Fig. 8D). tion (C, D).",
      "metadata": {
        "score": 0.9850302338600159,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0005271434783935547,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "e025fd59",
      "page_index": 6,
      "role": "Text",
      "bbox": [
        1678.94189453125,
        3610.887451171875,
        3131.512451171875,
        4091.881103515625
      ],
      "text": "20 40 60 80 100 58% 26% Flu zone IIV4 Fluarix IIV4 ccIIV4 RIV4 ccine virus (egg cell p=0.0001 A (H3N2) A (H1N1) pdm09 B/VIC B/YAM 18-44 years C",
      "metadata": {
        "score": 0.9956637024879456,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0001881122589111328,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "2a4d4f35",
      "page_index": 6,
      "role": "Text",
      "bbox": [
        222.9072265625,
        1637.187744140625,
        1635.233154296875,
        2223.84716796875
      ],
      "text": "A (H3N2) and B/VIC in the 18−44 years group, B/VIC virus and B/YAM virus in the 45−64 years group, suggesting repeated boost to anti- bodies targeting egg adapted epi to pes in these participants after receiving consecutive egg based IIV4 vaccination. In contrast, among recipients of non egg based vaccines in just one study year (IIV4-ccIIV4 or IIV4-RIV4) or in both study years (ccIIV4-ccIIV4, ccIIV4-RIV4, RIV4- ccIIV4, RIV4-RIV4), the proportions of participants with egg cell ratio each vaccine group. Proportions of participants who had ≥4 -fold reduced titer to",
      "metadata": {
        "score": 0.9766672849655151,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0007500648498535156,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "c94d2ab9",
      "page_index": 6,
      "role": "Text",
      "bbox": [
        1688.7481689453125,
        2345.69580078125,
        3132.415771484375,
        2778.47607421875
      ],
      "text": "cell vaccine virus (egg cell titer ratio) at pre- and 1 month post vaccination were presented for each vaccine component among the 4 vaccine groups for 18−44 years (C) and 45−64 years (D). Fisher’s exact test (two tailed was performed for comparing proportions of ≥4 -fold reduced titer to cell vaccine virus between pre- and 1 month post vaccination in each vaccine group. MN titers were measured for A (H3N2) virus, while HI titers were measured for A (H1N1) pdm09, B/VIC, and B/ YAM viruses. Statistically sign i cant differences between groups are indicated by p",
      "metadata": {
        "score": 0.9850019812583923,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0007519721984863281,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "bd161bc7",
      "page_index": 7,
      "role": "Figure",
      "bbox": [
        254.1129150390625,
        222.3218536376953,
        2990.32373046875,
        1971.3426513671875
      ],
      "text": "[FIGURE 1 - See figure_p8_bd161bc7.png]",
      "image_path": "figures/figure_p8_bd161bc7.png",
      "metadata": {
        "score": 0.9889081120491028,
        "detection_dpi": 400
      }
    },
    {
      "id": "a6f2d3ca",
      "page_index": 7,
      "role": "Text",
      "bbox": [
        216.4636993408203,
        3213.109130859375,
        1641.9747314453125,
        4148.6904296875
      ],
      "text": "A (H3N2) A (H1N1) pdm09 18-44 yrs egg virus 18-44 yrs cell virus Day 0 1 m 5 10 20 40 80 160 320 640 1280-2560 5120 HI titers (Log2 scale) Day 0 1 m 5 10 20 40 80 160 320 640 1280-2560 5120 <0 0001 0.011 0.013 <0 0001 Day 0 1 m 5 10 20 40 80 160 320 640 1280-2560 5120 HI titers (Log2 scale) Day 0 1 m 5 10 20 40 80 160 320 640 1280-2560 5120 0.02 0 0011",
      "metadata": {
        "score": 0.9972033500671387,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.00035500526428222656,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "5a588915",
      "page_index": 7,
      "role": "Text",
      "bbox": [
        1684.30224609375,
        2829.927734375,
        3138.831787109375,
        3613.8193359375
      ],
      "text": "Day 0 1 m 5 10 20 40 80 160 320 640 1280-2560 5120 HI titers (Log2 scale) Day 0 1 m 5 10 20 40 80 160 320 640 1280-2560 5120 0.004 0.01 Day 0 1 m 5 10 20 40 80 160 320 640 1280-2560 5120 HI titers (Log2 scale) Day 0 1 m 5 10 20 40 80 160 320 640 1280-2560 5120 0.04 <0 0001 0 0006 <0 0001 0.03 0 0002",
      "metadata": {
        "score": 0.9968967437744141,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.00036025047302246094,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "79d7bc7e",
      "page_index": 7,
      "role": "Text",
      "bbox": [
        213.4560089111328,
        2446.818603515625,
        1639.0169677734375,
        3150.94775390625
      ],
      "text": "B/VIC B/YAM Day 0 1 m 5 10 20 40 80 160 320 640 1280 HI titers (Log2 scale Day 0 1 m 5 10 20 40 80 160 320 640 1280 0.014 0 0003 Day 0 1 m 5 10 20 40 80 160 320 640 1280-2560 5120 HI titers (Log2 scale) Day 0 1 m 5 10 20 40 80 160 320 640 1280-2560 5120 0.006 0 0004 0 0004",
      "metadata": {
        "score": 0.9968070983886719,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0002911090850830078,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "fc653a63",
      "page_index": 7,
      "role": "Text",
      "bbox": [
        1687.7467041015625,
        3659.48779296875,
        3131.967041015625,
        4141.08154296875
      ],
      "text": "45-64 yrs egg virus 45-64 yrs cell virus Day 0 1 m 5 10 20 40 80 160 320 640 1280-2560 5120 HI titers (Log2 scale) Day 0 1 m 5 10 20 40 80 160 320 640 1280-2560 5120 ccIIV4-ccIIV4 ccIIV4-RIV4 RIV4-ccIIV4 RIV4-RIV4 IIV4-ccIIV4 IIV4-RIV4 IIV4-IIV4 0.007 0 0002",
      "metadata": {
        "score": 0.9975002408027649,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.00022411346435546875,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "bb229b61",
      "page_index": 7,
      "role": "Text",
      "bbox": [
        1690.9312744140625,
        2003.563232421875,
        3130.91357421875,
        2325.354736328125
      ],
      "text": "(n = 45), RIV4 RIV4 (n = 44), IIV4 ccIIV4 (n = 57), IIV4 RIV4 (n = 56), IIV4 IIV4 (n = 56). Unpaired t test (two tailed was used to compare the post vaccination GMTs to cell vaccine viruses between IIV4-IIV4 (Flu zone arm and each of the remaining 6 vac- cine arms within the same age group. Statistically sign i cant differences between groups are indicated by p values on the horizontal bars.",
      "metadata": {
        "score": 0.9928368926048279,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0006017684936523438,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "913cc9cf",
      "page_index": 7,
      "role": "Text",
      "bbox": [
        1675.8941650390625,
        2452.206787109375,
        3125.964111328125,
        2814.536865234375
      ],
      "text": "Day 0 1 m 5 10 20 40 80 160 320 640 1280-2560 5120 HI titers (Log2 scale) Day 0 1 m 5 10 20 40 80 160 320 640 1280-2560 5120 <0 0001 0.007 0 0006 <0 0001",
      "metadata": {
        "score": 0.9839062094688416,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.00021409988403320312,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "0c8d3c8e",
      "page_index": 7,
      "role": "Text",
      "bbox": [
        211.7949676513672,
        2117.96533203125,
        1659.4920654296875,
        2380.370849609375
      ],
      "text": "Fig. 6 | HI antibody responses to egg and cell propagated vaccine viruses at pre- and 1 month post vaccination in year 2 stratiﬁed by 7 repeat vaccination arms. HI antibody titers from each of the 7 repeat vaccine arms were presented as geometric mean titers (GMTs) with 95% conﬁdence interval (CI) respectively for 18−44 years and 45−64 years age groups. Gray dots represented i di id l tit 18 44 IIV4 IIV4 ( 42) IIV4 RIV4 ( 45) RIV4",
      "metadata": {
        "score": 0.9435644745826721,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0007259845733642578,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "bb29873f",
      "page_index": 7,
      "role": "Text",
      "bbox": [
        208.29293823242188,
        1977.3114013671875,
        1639.1668701171875,
        2004.8123779296875
      ],
      "text": "",
      "metadata": {
        "score": 0.585857629776001,
        "detection_dpi": 400,
        "extraction_status": "empty"
      }
    },
    {
      "id": "8d4f31bb",
      "page_index": 8,
      "role": "Figure",
      "bbox": [
        247.32528686523438,
        252.49923706054688,
        2987.381103515625,
        1765.4583740234375
      ],
      "text": "[FIGURE 1 - See figure_p9_8d4f31bb.png]",
      "image_path": "figures/figure_p9_8d4f31bb.png",
      "metadata": {
        "score": 0.9890084862709045,
        "detection_dpi": 400
      }
    },
    {
      "id": "fe4fde7e",
      "page_index": 8,
      "role": "Text",
      "bbox": [
        214.13819885253906,
        2140.619384765625,
        1646.168701171875,
        3227.189208984375
      ],
      "text": "IIV4 and ccIIV4 (15 µg HA/dose/strain). For A (H3N2), RIV4 vaccination not only improved the quality of the functional neutralizing antibody Fig. 7 | Dynamics of proportion of participants with HI GMT egg cell ratio ≥4 fold among seven repeat vaccination arms in Year 2. Proportions of Year 2 participants who had ≥4 -fold reduced titer to cell vaccine virus (egg cell titer ratio) at pre- and 1 month post vaccination were presented for each vaccine component among the seven Year 1-Year 2 vaccine arms. A: 18-44 years age group and B: 45−64",
      "metadata": {
        "score": 0.9937166571617126,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0008099079132080078,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "11eab3e6",
      "page_index": 8,
      "role": "Text",
      "bbox": [
        1687.677490234375,
        2156.340087890625,
        3134.94873046875,
        3147.533203125
      ],
      "text": "The impact of egg adaptation was the least profound on the b d ( ) d h d ( ) years age group. Fisher’s exact test (two tailed was performed for comparing proportions of ≥4 -fold reduced titer to cell vaccine virus between pre- and 1 month post vaccination in each vaccine group. P values noted on the corre- sponding trend lines indicate statistically sign i cant difference of the proportions between pre- and post vaccination.",
      "metadata": {
        "score": 0.9906414151191711,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0007169246673583984,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "9e30e383",
      "page_index": 8,
      "role": "Text",
      "bbox": [
        1687.8057861328125,
        3202.994384765625,
        3128.869384765625,
        4128.35595703125
      ],
      "text": "",
      "metadata": {
        "score": 0.9964202642440796,
        "detection_dpi": 400,
        "extraction_status": "empty"
      }
    },
    {
      "id": "05796456",
      "page_index": 8,
      "role": "Text",
      "bbox": [
        211.98439025878906,
        3259.2314453125,
        1656.1064453125,
        4148.9404296875
      ],
      "text": "",
      "metadata": {
        "score": 0.994428277015686,
        "detection_dpi": 400,
        "extraction_status": "empty"
      }
    },
    {
      "id": "9e3c6595",
      "page_index": 8,
      "role": "Text",
      "bbox": [
        229.20347595214844,
        1795.8912353515625,
        1682.0489501953125,
        2057.8355712890625
      ],
      "text": "p ( g ) y g gg/ years, it also signiﬁcantly increased the quantity of the total A (H3N2) cell HA head binding antibodies (Fig. 4A, Fig. S1A). However, for A (H1N1) pdm09 and B viruses, the difference in HI antibody versus the total HA head binding antibody levels among 4 vaccine groups was less i i h h i d f i diff",
      "metadata": {
        "score": 0.992159366607666,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0004010200500488281,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "d3680112",
      "page_index": 8,
      "role": "Text",
      "bbox": [
        1687.5003662109375,
        1772.0799560546875,
        3144.679931640625,
        2054.06005859375
      ],
      "text": "p gg p g have reported that Q223R egg adapted change at the HA head domain of A (H1N1) pdm09 virus can promote virus replication in eggs, alter antigen i city and inﬂuence immune response 37 42. In this study, 1 month post vaccination GMTs to both egg- and cell propagated A (H1N1) pdm09 vaccine viruses in year 1 were similar among the 4 vaccine",
      "metadata": {
        "score": 0.9740381836891174,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0006530284881591797,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "5f493709",
      "page_index": 9,
      "role": "Figure",
      "bbox": [
        311.1028137207031,
        231.19590759277344,
        3047.45361328125,
        1993.687744140625
      ],
      "text": "[FIGURE 1 - See figure_p10_5f493709.png]",
      "image_path": "figures/figure_p10_5f493709.png",
      "metadata": {
        "score": 0.986791729927063,
        "detection_dpi": 400
      }
    },
    {
      "id": "21e95eca",
      "page_index": 9,
      "role": "Text",
      "bbox": [
        216.6543731689453,
        2794.777587890625,
        1634.348388671875,
        3828.397216796875
      ],
      "text": "A (H1N1) pdm09 B/VIC Day 0 1 m 400 800 1600 ELISA ti Day 0 1 m 400 800 1600 Day 0 1 m 400 800 1600-3200 6400-12800 25600-51200 ELISA titers (Log2 scale) Day 0 1 m 400 800 1600-3200 6400-12800 25600-51200 Day 0 1 m 400 800 1600-3200 6400-12800 25600-51200 ELISA titers (Log2 scale) Day 0 1 m 400 800 1600-3200 6400-12800 25600-51200 0.005",
      "metadata": {
        "score": 0.9935289025306702,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.00030303001403808594,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "4396d67d",
      "page_index": 9,
      "role": "Text",
      "bbox": [
        1699.6368408203125,
        2793.494873046875,
        3120.333251953125,
        3644.38623046875
      ],
      "text": "Day 0 1 m 200 400 800 1600-3200 6400 ELISA titers (Log2 scale) IIV4-ccIIV4 IIV4-RIV4 IIV4-IIV4 ccIIV4-ccIIV4 ccIIV4-RIV4 RIV4-ccIIV4 RIV4-RIV4 * * * * Day 0 1 m 200 400 800 1600-3200 6400-12800 25600 ELISA titers (Log2 scale) 0.037 0.037 0.017 * * H3 stalk H1 stalk A C D 2",
      "metadata": {
        "score": 0.9869112968444824,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.00021886825561523438,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "3e0aecbc",
      "page_index": 9,
      "role": "Text",
      "bbox": [
        1708.85791015625,
        2021.78564453125,
        3125.5283203125,
        2642.45361328125
      ],
      "text": "0 1 2 RIV4-ccIIV4 RIV4-RIV4 IIV4-ccIIV4 IIV4-RIV4 IIV4-IIV4 H3 stalk H1 stalk Geometric mean fold titers to HA stalk within the same age group (A). One way ANOVA corrected for multiple com par isons (Tukey’s test) was used to compare the GMTs of stalk binding antibody at each time point among the 4 vaccine groups (C). One way ANOVA non parametric Kruskal-Wallis test was used to compare the fold changes among the 4 vaccine groups (B, D). Statistically sign i cant differences between groups are indicated by p values on the horizontal bars (A, C). *In (C), paired t test (two tailed was used for",
      "metadata": {
        "score": 0.9808952212333679,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0008280277252197266,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "1693d0cc",
      "page_index": 9,
      "role": "Text",
      "bbox": [
        1685.35107421875,
        3661.599609375,
        3137.20556640625,
        4142.96484375
      ],
      "text": "B 0 1 2 3 4 ccIIV4-ccIIV4 ccIIV4-RIV4 RIV4-ccIIV4 RIV4-RIV4 IIV4-ccIIV4 IIV4-RIV4 IIV4-IIV4 H3 HA H1 HA B/VIC HA B/YAM HA Geometric mean ratio of ELISA titer egg cell HA (95% CI) ccIIV4-ccIIV4 ccIIV4-RIV4 RIV4-ccIIV4 RIV4-RIV4 IIV4-ccIIV4 IIV4-RIV4 IIV4-IIV4 Egg cell HA ELISA \u0002ter ra\u0002o (1m)",
      "metadata": {
        "score": 0.9932246804237366,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.00020694732666015625,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "b845c9e5",
      "page_index": 9,
      "role": "Text",
      "bbox": [
        223.3015594482422,
        2323.449462890625,
        1636.8570556640625,
        2709.406005859375
      ],
      "text": "B/YAM Day 0 1 m 400 800 1600-3200 6400-12800 25600 ELISA titers (Log2 sca Day 0 1 m 400 800 1600-3200 6400-12800 25600 Fig. 8 | HA head and stalk binding antibody responses measured by ELISA at",
      "metadata": {
        "score": 0.9826767444610596,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0002529621124267578,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "eb3939cb",
      "page_index": 9,
      "role": "Text",
      "bbox": [
        217.66224670410156,
        3853.173095703125,
        1647.857666015625,
        4147.5009765625
      ],
      "text": "A (H3N2) A Egg virus HA Cell virus HA 3200-6400 12800-25600 51200 rs (Log2 scale) 3200-6400 12800-25600 51200 0.039",
      "metadata": {
        "score": 0.9959576725959778,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.000102996826171875,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "86c6f9bd",
      "page_index": 9,
      "role": "Text",
      "bbox": [
        214.52276611328125,
        2026.085205078125,
        1646.1739501953125,
        2272.984619140625
      ],
      "text": "pre and 1 month post vaccination in 7 repeat vaccination arms. Antibody titers from each of the 7 vaccine arms were presented as geometric mean titers (GMTs) with 95% conﬁdence interval (CI) for combined 18−44 years and 45−64 years age groups. Gray dots represented individual titers. ccIIV4-ccIIV4 (n = 20), ccIIV4-RIV4 (n = 22), RIV4-ccIIV4 (n = 16), RIV4-RIV4 (n = 16), IIV4-ccIIV4 (n = 22), IIV4-RIV4",
      "metadata": {
        "score": 0.9686485528945923,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0005249977111816406,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "58ccc7bc",
      "page_index": 10,
      "role": "Text",
      "bbox": [
        1695.8438720703125,
        1606.1195068359375,
        3134.110107421875,
        3125.109130859375
      ],
      "text": "gg g g p 0019-2016 viruses were tested in MN as says in year 1 using MDCK-SIAT1 cells using methods as previously described 44. In Year 2, egg- and cell- propagated A/Kansas/14/2017 viruses were tested by HI as says using 0.75% guinea pig erythrocytes in the presence of 20 nM oseltamivir. Enzyme linked immunosorbent assay (ELISA) Twenty percent of participants were selected by random sampling from each vaccine group and age strata (18−44 yrs and 45−64 yrs) in year 1 (n = 144) and year 2 (n = 140), the MN/HI antibody levels of the subset are representative of the whole study populations in year 1 (Fig. S3) and year 2 (Fig. S4). These serum samples were tested by ELISA to evaluate the total binding antibodies against 8 recombinant HA proteins (rHA from both egg and cell propagated viruses of each of the 4 vaccine antigens), and 2 rHA stalk proteins (A (H1N1) pdm09 HA stalk, and A (H3N2) HA stalk). rHA from egg- and cell A/Michigan/45/2015 (H1N1) pdm09, rHA head from egg- and cell- A/Singapore/INFIMH-16-0019/2016 (H3N2), B/ Colorado 06 2017 (B/Victoria), and B/Phuket/3073/2013 (B/Yamagata) were tested with year 1 sera; rHA from egg- A/Brisbane/02/2018 (H1N1) pdm09 and cell-A/Idaho/7/2018 (H1N1) pdm09, rHA head from egg- and cell- A/Kansas/14/2017 (H3N2), egg- and cell- B/Colorado/06/2017 (B/ Victoria), egg- and cell-B/Phuket/3073/2013 (B/Yamagata) were tested with year 2 sera. The puriﬁed and trim eric recombinant HA proteins were expressed from the baculovirus system using the established procedures 45. For ELISA, rHA antigens were coated at 100 ng/well. Serum samples were tested at an initial dilution of 1:400 followed by 2 fold serial dilution Antibodies were detected by horseradish per oxidase",
      "metadata": {
        "score": 0.9758256077766418,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0023839473724365234,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "11662533",
      "page_index": 10,
      "role": "Table",
      "bbox": [
        229.7332305908203,
        349.2281799316406,
        1648.60986328125,
        1732.416015625
      ],
      "text": "[TABLE 2 - See table_p11_11662533.png]",
      "image_path": "figures/table_p11_11662533.png",
      "metadata": {
        "score": 0.9312294721603394,
        "detection_dpi": 400
      }
    },
    {
      "id": "de79b840",
      "page_index": 10,
      "role": "Text",
      "bbox": [
        209.7328338623047,
        2169.785400390625,
        1642.1112060546875,
        3048.9140625
      ],
      "text": "ﬁndings from comparative immunogen i city studies and provide additional information to identify optimal vaccination strategies to prevent inﬂuenza. Materials and methods Study design The original study was a randomized, open label trial conducted in the KPNW 49 40 45 37 136 48 51 26 Prior inﬂuenza vaccination history Receipt of inﬂuenza vacicnes in all the last 5 seasons 83 68 93 78 209 74 135 68 Prior season vaccination (2017-2018 108 89 104 87 245 87 176 89",
      "metadata": {
        "score": 0.9976794123649597,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0009908676147460938,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "25c65c5f",
      "page_index": 10,
      "role": "Text",
      "bbox": [
        1688.3798828125,
        883.9917602539062,
        3118.976318359375,
        1539.3131103515625
      ],
      "text": "(HRP) conjugated goat anti human pan immunoglobulin conjugate to detect total binding antibodies. ELISA was performed based on pre- viously described procedures 46 47. The ELISA titers were determined as the reciprocal of the highest dilution of serum samples that achieved an optical density (OD) value of 0.2 or greater. Sequence analyses All the testing viruses used in this study were sequenced. Sequences were analyzed against the sequences of candidate vaccine viruses (CVV) of the study vaccines as deposited in Global Initiative on Sharing Avian Inﬂuenza Data (GISAID) database by BioEdit version 7 0 9 0 (Table 1).",
      "metadata": {
        "score": 0.9966081380844116,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0010187625885009766,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "ac705304",
      "page_index": 10,
      "role": "Text",
      "bbox": [
        210.36561584472656,
        3084.53466796875,
        1661.5477294921875,
        3666.19970703125
      ],
      "text": "Mean age, years (SD) 43 (11) 45 (11) 44 (11) 43 (12) Age Group 18−44 years 57 47 55 46 135 48 99 50 45−64 years 65 53 65 54 148 52 99 50 Female 107 88 103 86 233 82 157 79 White 110 90 94 78 232 82 148 75 Hispanic 13 11 19 16 37 13 37 19 Site BSWH 73 60 75 63 147 52 147 74",
      "metadata": {
        "score": 0.9951483607292175,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.00015425682067871094,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "e2b71281",
      "page_index": 10,
      "role": "Text",
      "bbox": [
        1678.679443359375,
        248.31900024414062,
        3122.493408203125,
        853.4425048828125
      ],
      "text": "Statistical analyses Geometric mean titers (GMTs) at day 0, 1 month and 6 months, geo- metric mean fold rise (GMFR) of antibody titers at 1 month versus day 0, and geometric mean fold reduction of antibody titers at 6 months versus 1 month were calculated per vaccine group. “GMT egg cell titer ratio” (ratio = GMT to egg grown vaccine virus or rha gmt to cell- grown vaccine virus or rHA) was calculated to quantify the difference in antibody response to egg- versus corresponding cell propagated vaccine virus for each vaccine group. The proportion of participants",
      "metadata": {
        "score": 0.9888134598731995,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0008161067962646484,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "3d102c91",
      "page_index": 10,
      "role": "Text",
      "bbox": [
        1684.0684814453125,
        3578.77294921875,
        3132.70361328125,
        4089.744384765625
      ],
      "text": "were propagated in 10 day old embryonated chicken eggs. Cell grown A (H1N1) pdm09 and inﬂuenza B viruses were propagated in Mad in Darby canine kidney (MDCK) cells. Inﬂuenza B antigens were ether- treated prior to use in the HI as says. Egg- and cell (MDCK)-propagated A/Michigan/45/2015 (H1N1) pdm09, B/Colorado/06/2017 (B/Victoria), and B/Phuket/3073/2013 (B/Yamagata) viruses were tested in year 1, Egg propagated A/Brisbane/02/2018 (H1N1) pdm09, cell propagated A/Idaho/7/2018 (H1N1) pdm09, egg- and cell propagated B/Colorado/ 06 2017 (B/Victoria) and B/Phuket/3073/2013 (B/Yamagata) viruses t t d i 2 b HI i 0 5% t k th t",
      "metadata": {
        "score": 0.9943296313285828,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0006690025329589844,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "be604bd2",
      "page_index": 10,
      "role": "Text",
      "bbox": [
        219.947998046875,
        3816.4365234375,
        1642.9425048828125,
        4083.1689453125
      ],
      "text": "| p y Flu zone IIV4 Fluarix IIV4 ccIIV4 RIV4 n = 122 n = 120 n = 283 n = 198 % % % %",
      "metadata": {
        "score": 0.9922027587890625,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.00011801719665527344,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "b7089919",
      "page_index": 10,
      "role": "Text",
      "bbox": [
        1680.8013916015625,
        3233.8447265625,
        3134.23828125,
        3491.384033203125
      ],
      "text": "Antibody responses to A (H3N2) viruses were analyzed by MN as says in year 1 (the cell grown vaccine antigen of the study year does not hemagglutinate in the HI as says, and HI as says in year 2. Egg grown A (H3N2) viruses were propagated in 10 day old embryonated chicken eggs, cell grown A (H3N2) viruses were propagated in stably trans fec ted",
      "metadata": {
        "score": 0.9603851437568665,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0007162094116210938,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "6e123b0f",
      "page_index": 10,
      "role": "Title",
      "bbox": [
        214.4915313720703,
        2031.6810302734375,
        877.9783325195312,
        2143.15283203125
      ],
      "text": "United States during the Norther 2019-2020 (Year 2) inﬂuenza s l i Th d t il d ti i",
      "metadata": {
        "score": 0.9908692836761475,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.00017523765563964844,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "c9b48c04",
      "page_index": 10,
      "role": "Text",
      "bbox": [
        220.4646759033203,
        1798.4490966796875,
        1647.48779296875,
        1998.517333984375
      ],
      "text": "y p p , , blinding were previously described 27 29. Participant characterisitcs in year 1 are described in Table 2. During Year 1, HCP were stratiﬁed by two age groups (18−44 years and 45−64 years) and randomized at 4 4 2 2 i i f f d i l i ( l l )",
      "metadata": {
        "score": 0.910418689250946,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0004611015319824219,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "d144c9d1",
      "page_index": 10,
      "role": "Title",
      "bbox": [
        206.89393615722656,
        253.25723266601562,
        1265.6812744140625,
        335.13580322265625
      ],
      "text": "p g y y y",
      "metadata": {
        "score": 0.631686806678772,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.000018835067749023438,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "22356d17",
      "page_index": 11,
      "role": "List",
      "bbox": [
        207.77891540527344,
        1088.760498046875,
        1747.5634765625,
        4148.3125
      ],
      "text": "with MN or HI GMT egg cell titer ratio ≥4 fold was calculated to quantify the percent of participants with antibodies predominantly targeting egg adapted epi to pes per vaccine group. One way ANOVA corrected for multiple comparisons (Tukey’s test) or non parametric Kruskal-Wallis test was used for multiple group comparison, two tailed paired t test was used to compare pre- and post vaccination; two tailed unpaired t test was used to compare the post vaccination titers between IIV4-IIV4 (Flu zone arm and each of the remaining 6 arms in Year 2; Two tailed Fisher’s exact test was used for comparing pro- portions. P < 0.05 is considered statistically sign i cant. SAS 9.4 (SAS Institute) and GraphPad Prism 8 (GraphPad Software, Inc.) were used for statistical analyses. Ethic review The study protocol was reviewed and approved by the institutional review boards (IRBs) of the study sites and the Centers for Disease Control and Prevention. Informed consent was obtained from the par- tic i pants. This study is registered on ClinicalTrials.gov, NCT03722589. Reporting summary Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article. Data availability The data that support the ﬁndings of this study are included in the manuscript, supplementary information, and the ﬁgshare repository https://doi.org/10.6084/m9.ﬁgshare.22666231. Additional raw data from the study are available from the corresponding author (mlevi- ne@cdc.gov) upon request. References 1. Flannery, B. et al. Inﬂuenza vaccine effectiveness in the United States during the 2016-2017 season. Clin. Infect. Dis. 68, 1798-1806 (2019). 2. Levine, M. Z. et al. Antibodies Against Egg- and Cell-Grown Inﬂu- enza A (H3N2) viruses in adults hospitalized during the 2017-2018 inﬂuenza season. J. Infect. Dis. 219, 1904-1912 (2019). 3. Liu, F. et al. Age-speciﬁc effects of vaccine egg adaptation and immune priming on A (H3N2) antibody responses following inﬂu- enza vaccination. J. Clin. Investig. 131, e146138 (2021). 4. Rolfes, M. A. et al. Effects of Inﬂuenza Vaccination in the United States During the 2017-2018 Inﬂuenza Season. Clin. Infect. Dis. 69, 1845-1853 (2019). 5. Wu, N. C.et al. A structural explanation for the low effectiveness of the seasonal inﬂuenza H3N2 vaccine. PLoS Pathog. 13, e1006682 (2017). 6. Zost, S. J. et al. Contemporary H3N2 inﬂuenza viruses have a gly- cosylation site that alters binding of antibodies elicited by egg- adapted vaccine strains. Proc. Natl. Acad. Sci. USA 114, 12578-12583 (2017). 7. Barr, I. G. et al. Cell culture derived inﬂuenza vaccines in the severe 2017-2018 epidemic season: a step towards improved inﬂuenza 13. 14. 15. 16. 17. 18. 19. 20 21. 22 23 24 25 26 27",
      "metadata": {
        "score": 0.9271237254142761,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.005093097686767578,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "ff28f38c",
      "page_index": 11,
      "role": "List",
      "bbox": [
        219.4698028564453,
        250.2080078125,
        1702.458740234375,
        1053.3736572265625
      ],
      "text": "vaccine effectiveness. NPJ Vaccines 3, 44 (2018). 8. Dunkle, L. M. et al. Randomized comparison of immunogen i city and safety of quad rival ent recombinant versus in activated inﬂuenza vaccine in healthy adults 18-49 years of age. J. Infect. Dis. 216, 1219-1226 (2017). 9. Dunkle, L. M. et al. Safety and immunogen i city of a recombinant inﬂuenza vaccine: a randomized trial. Pediatrics 141, e20173021 (2018). 10. Nolan, T. et al. Efﬁcacy of a cell culture derived quad rival ent inﬂu- enza vaccine in children. N. Engl. J. Med. 385, 1485-1495 (2021). 11. Moehling, K. K. et al. A randomized controlled trial of antibody response to 2018-19 cell based vs. egg based quad rival ent in act i vated inﬂuenza vaccine in children. Vaccine 38, 5171-5177 (2020). 12. Hart vick son, R. et al. Non inferiority of mammalian cell derived quad rival ent subunit inﬂuenza virus vaccines compared to trivalent 2 2",
      "metadata": {
        "score": 0.6372452974319458,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0018990039825439453,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "13bea8bc",
      "page_index": 11,
      "role": "List",
      "bbox": [
        1758.8314208984375,
        3956.435302734375,
        3004.971923828125,
        4136.07568359375
      ],
      "text": "subunit inﬂuenza virus vaccines in healthy children: a phase randomized, multi center, double blind clinical trial. Int. J. Infe Dis. 41, 65–72 (2015).",
      "metadata": {
        "score": 0.44370824098587036,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.00029921531677246094,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "2bf6001b",
      "page_index": 11,
      "role": "Text",
      "bbox": [
        1763.05712890625,
        2933.460205078125,
        3116.34619140625,
        3128.4599609375
      ],
      "text": "p g Dis. 71, e665–e671 (2020). Thompson, M. G. et al. Effects of repeated annual in activated inﬂuenza vaccination among healthcare personnel on serum",
      "metadata": {
        "score": 0.27772098779678345,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0003352165222167969,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "6956dccc",
      "page_index": 11,
      "role": "Text",
      "bbox": [
        1813.0921630859375,
        2118.083984375,
        3124.41015625,
        2412.424072265625
      ],
      "text": "p y y maturation across different inﬂuenza vaccine platforms in humans. Nat. Com mun. 10, 3338 (2019). Keitel, W. A., Cate, T. R., Couch, R. B., Huggins, L. L. & Hess, K. R. Efﬁcacy of repeated annual immunization with in activated inﬂuenza virus vaccines over a ﬁve year period. Vaccine 15, 1114-1122 (1997).",
      "metadata": {
        "score": 0.22951056063175201,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0005931854248046875,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "85d658da",
      "page_index": 12,
      "role": "List",
      "bbox": [
        179.36402893066406,
        223.18634033203125,
        3134.603515625,
        3643.740234375
      ],
      "text": "systematic review and meta analysis. Lancet Res pir. Med. 11, 27–44 (2023). 34. Shaw, M. W. et al. Reappearance and global spread of variants of inﬂuenza B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasons. Virology 303, 1–8 (2002). 35. Saito, T. et al. Antigenic alteration of inﬂuenza B virus associated with loss of a glycosylation site due to host cell adaptation. J. Med. Virol. 74, 336 343 (2004). 36. Robertson, J. S. et al. Alterations in the hemagglutinin associated with adaptation of inﬂuenza B virus to growth in eggs. Virology 143, 166 174 (1985). 37. Raymond, D. D. et al. Inﬂuenza immunization elicits antibodies speciﬁc for an egg adapted vaccine strain. Nat. Med. 22, 1465-1469 (2016). 38. Liu, F. et al. Inﬂuence of immune priming and egg adaptation in the vaccine on antibody responses to circulating A (H1N1) pdm09 viru- ses after inﬂuenza vaccination in adults. J. Infect. Dis. 218, 1571-1581 (2018). 39. Koel, B. F. et al. Ident i cation of amino acid substitutions supporting antigenic change of inﬂuenza A (H1N1) pdm09 viruses. J. Virol. 89, 3763-3775 (2015). 40. Koel, B. F. et al. Substitutions near the receptor binding site deter- mine major antigenic change during inﬂuenza virus evolution. Sci- ence 342, 976 979 (2013). 41. Chen, Z. et al. Generation of live attenuated novel inﬂuenza virus A/ California 7 09 (H1N1) vaccines with high yield in embryonated chicken eggs. J. Virol. 84, 44–51 (2010). 42. Caton, A. J., Brown lee, G. G., Yew dell, J. W. & Gerhard, W. The antigenic structure of the inﬂuenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31, 417 427 (1982). 43. Network WGIS. Manual for the laboratory diagnosis and virological surveillance of inﬂuenza. https://iris.who.int/bitstream/handle/ 10665-44518 9789241548090 eng pdf sequence 1 (2011). 44. Gross, F. L., Bai, Y., Jefferson, S., Holiday, C. & Levine, M. Z. Mea- suring Inﬂuenza Neutralizing Antibody Responses to A (H3N2) Viru- ses in Human Sera by Micro neutralization As says Using MDCK-SIAT1 Cells. J. Vis. Exp. 56448, https doi org 10 3791-56448 (2017). 45. Stevens, J. et al. Structure of the uncleaved human H1 hemagglu- tinin from the extinct 1918 inﬂuenza virus. Science 303, 1866-1870 (2004). 46. Li, Z. N. et al. IgM, IgG, and IgA antibody responses to inﬂuenza A (H1N1) pdm09 hemagglutinin in infected persons during the ﬁrst wave of the 2009 pandemic in the United States. Clin. Vaccin. Immunol. 21, 1054-1060 (2014). 47. Li, Z. N. et al. Serologic evidence of inﬂuenza A (H1N1) pdm09 virus infection in northern sea otters. Emerg. Infect. Dis. 20, 915 917 (2014). Acknowledgements We thank the staff from Baylor Scott & White Health and Kaiser Perm a nente Northwest for their participation and support of the study. We Author contributions M. Z. L., F. S. D., B. F., A. M. F., M. G. T., T. T., M. G. and A. L. N. were involved in the conception and the design of the studies. F. L., F. L. G., S. J., K. M., H. G., M. G. W., L. J. E., L. G., S. S. K., S. S., S. G., performed the studies and acquired the data. F. L. and S. J. analyzed the data. F. L. and M. Z. L. wrote the manuscript. M. Z. L. supervised the study. All co-authors were involved in manuscript preparation process for important intellectual content. Competing interests M. G.received funding from Pﬁzer for an unrelated educational grant and Janssen for an unrelated study. A. L. N. received research funding from Pﬁzer and Vir Biotechnology for unrelated studies. All other authors declared no con ict of interest. Additional information Supplementary information The online version contains supplementary material available at https://doi.org/10.1038/s41467-023-44551-x. Correspondence and requests for materials should be addressed to Min Z. Levine. Peer review information Nature Communications thanks Sure nder Khurana and the other, anonymous, reviewer (s) for their contribution to the peer review of this work. Reprints and permissions information is available at http www nature com reprints Publisher’s note Springer Nature remains neutral with regard to jur- isdictional claims in published maps and institutional afﬁliations. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author (s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http creative commons org licenses by 4 0. © This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2024 1Inﬂuenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA. 2Baylor Scott & White Health, Temple, TX, USA. 3Baylor College of Medicine, Temple, TX, USA. 4Texas A & M University, College of Medicine, Temple, TX, USA. 5Kaiser Permanente Northwest Center for Health Research, Portland, OR, USA. 6Abt Associates, Atlanta, GA, USA. e-mail: mlevine@cdc.gov",
      "metadata": {
        "score": 0.9623817205429077,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.008890151977539062,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "8c2228fc",
      "page_index": 12,
      "role": "Text",
      "bbox": [
        216.9911651611328,
        3842.242431640625,
        3124.77099609375,
        4037.918212890625
      ],
      "text": "States During the 2018-2019 Inﬂuenza Season. Clin. Infect. Dis. 71, e368–e376 (2020). 32. Ramsay, L. C. et al. The impact of repeated vaccination on inﬂuenza vaccine effectiveness: a systematic review and meta analysis. BMC CDC for providing the recombinant HA proteins. We also thank Makeda Kay and Stacie Jefferson from inﬂuenza division of CDC for their assis- tance with the study. Funding: This study was funded by the US Centers for Disease Control and Prevention (contract 75D30118F02850). Dis-",
      "metadata": {
        "score": 0.9903113842010498,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": true,
          "processing_time": 0.0010001659393310547,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "5fbcaab8",
      "page_index": 12,
      "role": "Title",
      "bbox": [
        209.28500366210938,
        115.77310180664062,
        406.86859130859375,
        200.97254943847656
      ],
      "text": "Nature Co",
      "metadata": {
        "score": 0.4699781835079193,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18000000000000002,
          "text_modified": false,
          "processing_time": 0.0000457763671875
        }
      }
    }
  ],
  "reading_order": [
    [
      "ae95965e",
      "6bba299e",
      "97e3efc5",
      "de61779d",
      "c3da45a2",
      "d04ead38",
      "d43d597f",
      "27ced49e"
    ],
    [
      "bc3de884",
      "12410438",
      "332637ad",
      "7104fc5f",
      "80465f33",
      "ed776aac"
    ],
    [
      "74fc894d",
      "ba740d83",
      "9020031b",
      "46957b27",
      "dbed8dfa",
      "90fd2f83"
    ],
    [
      "896d15ed",
      "2c8a6aa8",
      "09c80957",
      "b931e8ed",
      "af7e3b71",
      "9c9aa4f0",
      "bf700b25"
    ],
    [
      "a8f63755",
      "3ad42e63",
      "402687fb",
      "ac784943",
      "97aefe6e",
      "0e817002",
      "11dd2a9a",
      "7a9ad4c3",
      "0b85105e",
      "95d6b527",
      "7754cba1"
    ],
    [
      "4bae8cb8",
      "4d3aadfe",
      "680c82c4",
      "c5b62358",
      "de591114",
      "0fa5a353",
      "0f9df376",
      "081d90d3",
      "403049a3",
      "0a953a42",
      "8f40dd3e"
    ],
    [
      "3f1ebe73",
      "2a4d4f35",
      "588256e6",
      "e75aa04e",
      "c88f85a2",
      "c94d2ab9",
      "373de897",
      "e025fd59"
    ],
    [
      "bd161bc7",
      "bb29873f",
      "0c8d3c8e",
      "79d7bc7e",
      "a6f2d3ca",
      "bb229b61",
      "913cc9cf",
      "5a588915",
      "fc653a63"
    ],
    [
      "8d4f31bb",
      "9e3c6595",
      "fe4fde7e",
      "05796456",
      "d3680112",
      "11eab3e6",
      "9e30e383"
    ],
    [
      "5f493709",
      "86c6f9bd",
      "b845c9e5",
      "21e95eca",
      "eb3939cb",
      "3e0aecbc",
      "4396d67d",
      "1693d0cc"
    ],
    [
      "d144c9d1",
      "11662533",
      "c9b48c04",
      "6e123b0f",
      "de79b840",
      "ac705304",
      "be604bd2",
      "e2b71281",
      "25c65c5f",
      "58ccc7bc",
      "b7089919",
      "3d102c91"
    ],
    [
      "ff28f38c",
      "22356d17",
      "6956dccc",
      "2bf6001b",
      "13bea8bc"
    ],
    [
      "5fbcaab8",
      "85d658da",
      "8c2228fc"
    ]
  ],
  "metadata": {
    "detection_dpi": 400,
    "total_pages": 13,
    "merge_settings": {
      "merge_overlapping": true,
      "merge_threshold": 0.3,
      "confidence_weight": 0.7,
      "area_weight": 0.3
    },
    "extraction": {
      "text_blocks": 85,
      "figure_blocks": 11,
      "figures_dir": "data/cache/Liu_et_al.__2024_/extracted/figures"
    }
  }
}